TABLE 4.
Prevalence of positive samples for fungal pathogens.
| Type of sample/specimen | Year | p | ||||
|---|---|---|---|---|---|---|
| 2020 (n = 225) | 2021 (n = 325) | 2022 (n = 449) | 2023 (n = 433) | Total (n = 1432) | ||
| Urine | 145 (64.4%) | 206 (63.4%) | 272 (60.6%) | 255 (58.9%) | 878 (61.3%) | 0.005* |
| Blood (central) | 32 (14.2%) | 55 (16.9%) | 88 (19.6%) | 96 (22.2%) | 271 (18.9%) | |
| Wound swab | 13 (5.8%) | 28 (8.6%) | 24 (5.3%) | 16 (3.7%) | 81 (5.7%) | |
| Nasal swab | 8 (3.6%) | 12 (3.7%) | 11 (2.4%) | 10 (2.3%) | 41 (2.9%) | |
| Tissue | 1 (0.4%) | 3 (0.9%) | 22 (4.9%) | 11 (2.5%) | 37 (2.6%) | |
| Blood (peripheral) | 6 (2.7%) | 5 (1.5%) | 8 (1.8%) | 12 (2.8%) | 31 (2.2%) | |
*
p < 0.001 is highly significant.